Patents by Inventor Marvin Lloyd Woodhouse

Marvin Lloyd Woodhouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for treating spinal muscular atrophy
    Patent number: 11938136
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: March 26, 2024
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy Mccarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse
  • COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY
    Publication number: 20200323856
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Application
    Filed: November 15, 2019
    Publication date: October 15, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem ALSENZ, Olaf GRASSMANN, Peter KUEHL, Friedrich METZGER, Kathleen Dorothy MCCARTHY, Eduardo Paulo Morawski VIANNA, Marvin Lloyd WOODHOUSE
  • COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY
    Publication number: 20180289712
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Application
    Filed: April 17, 2018
    Publication date: October 11, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy McCarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse